KOSS Koss Corp

  1. Stocks
  2. Technology
  3. NASDAQ: KOSS

Price (delayed)

$4.05

Market cap

$38.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.11

Enterprise value

$36.46M

?
Relative Growth: Rel. Growth: 12
Relative Strength: Rel. Strength: 26
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 23

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data ...

Highlights
The quick ratio has surged by 63% year-on-year and by 25% since the previous quarter
Koss's debt has decreased by 9% QoQ
Koss's net income has decreased by 46% YoY and by 26% from the previous quarter
Koss's EPS has decreased by 38% from the previous quarter and by 38% YoY
Sector: Technology
Industry: Consumer Electronics
Website: http://www.koss.com
Peers: UEIC

Key stats

What are the main financial stats of KOSS

KOSS stock price

How has the Koss stock price performed over time
Intraday
2.53%
1 week
0.5%
1 month
-3.34%
1 year
-18.84%
YTD
-2.17%
QTD
13.13%

Financial performance

How have Koss's revenue and profit performed over time
Revenue
$12.84M
Gross profit
$4.57M
Operating income
-$2.22M
Net income
-$1.1M
Gross margin
35.6%
Net margin
-8.6%
Koss's net income has decreased by 46% YoY and by 26% from the previous quarter
Koss's net margin has decreased by 41% YoY and by 26% QoQ
The operating income has contracted by 37% YoY and by 10% from the previous quarter
KOSS's operating margin is down by 33% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does KOSS's price correlate with its fundamentals

Growth

What is Koss's growth rate over time

Valuation

What is Koss stock price valuation
KOSS P/E details
P/E
N/A
P/B
1.29
P/S
2.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.84
Koss's EPS has decreased by 38% from the previous quarter and by 38% YoY
KOSS's P/B is 48% below its 5-year quarterly average of 2.4 and 10% below its last 4 quarters average of 1.4
The equity has declined by 3.1% year-on-year
The stock's P/S is 27% below its 5-year quarterly average of 4.0 and 12% below its last 4 quarters average of 3.3
KOSS's revenue is up by 3.3% year-on-year

Efficiency

How efficient is Koss business performance
KOSS's ROIC has shrunk by 50% YoY and by 27% QoQ
The company's return on equity has shrunk by 50% YoY and by 29% QoQ
Koss's ROA has plunged by 50% YoY and by 30% from the previous quarter
Koss's ROS has decreased by 44% YoY and by 27% from the previous quarter

Dividends

What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOSS.

Financial health

How did Koss financials performed over time
The quick ratio has surged by 63% year-on-year and by 25% since the previous quarter
The current ratio has grown by 49% YoY and by 20% from the previous quarter
Koss's debt is 100% lower than its equity
Koss's debt has decreased by 9% QoQ
The equity has declined by 3.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.